Compliments | News

Site Profile | Our Team

01920769933

Ambulances

Diagnoses

Organs

Diseases

Welcome

“May all be happy, may all be healed, may all be at peace and may no one ever suffer."

Beximco Pharmaceuticals Ltd.

N/A, N/A

...

Company Manuals

Carnovas HZ 2.5mg + 12.5mg

Size: 30 Price: 360.00

Tablet

Nebivolol + Hydrochlorothiazide

Combined antihypertensive preparations

0.00 (0)

2 Alternate Brands

Alternate Strengths

2.5mg + 12.5mg

Generic for Diseases

Generic Indications

Generic Description

The Combination of these ingredients has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone. This combination has mild vasodilating properties which reduces heart rate and blood pressure in hypertensive patients. Hydrochlorothiazide affects the renal tubular mechanisms of electrolyte reabsorption which directly increase the excretion of sodium and chloride in approximately equivalent amounts. The diuretic action of Hydrochlorothiazide reduces plasma volume, increases plasma renin activity and increases aldosterone secretion.

Component

Drug Indication

Essential hypertension

Dosage Administration

Once daily, preferably at the same time every day.

Contraindication

Hypersensitivity to the active substances, Liver function impairment. Severe renal insufficiency (Creatinine clearance < 30 ml/min.), Bradycardia, Hypotension

Side Effect

Nebivolol: Headache, Dizziness, Tiredness, Diarrhoea, Constipation, Nausea etc.

Hydrochlorothiazide: Vertigo, Itchiness, Rash, Increased sensitivity of skin to sunlight etc.

Overdose Effects

No data are available on Overdosage. Overdosage with Hydrochlorothiazide is associated with electrolyte depletion and dehydration resulting from excessive diuresis.

Precaution Warning

Nebivolol: Beta-blockers should not be used in patients with untreated Congestive Heart Failure (CHF) & bradycardia. In patients with Chronic Obstructive Pulmonary Diseases (COPD), beta-blockers should be used with caution as airway constriction may be aggravated.

Hydrochlorothiazide: In patients with renal disease, thiazides may increase azotaemia. If progressive renal impairment becomes evident, careful reappraisal of therapy is necessary. Thiazides can cause fluid or electrolyte imbalance. Thiazides may decrease urinary calcium excretion and may cause slight elevation of serum calcium in the absence of known disorders of calcium metabolism

Use in Special Populations

Use in children is not recommended.